A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

BENGALURU] European shares closed lower on Friday (Jul 11), as losses in banks and healthcare stocks weighed at the end of a ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Wockhardt announces its exit from the US generics market, shifting focus to its innovative antibiotic and biologicals ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a popular platform reveals the hidden risks of online prescriptions.

Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three ...

TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a ...